HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of a single prophylactic preoperative oral antibiotic dose on surgical site infection following complex dermatological procedures on the nose and ear: a prospective, randomised, controlled, double-blinded trial.

AbstractOBJECTIVES:
There is limited published research studying the effect of antibiotic prophylaxis on surgical site infection (SSI) in dermatological surgery, and there is no consensus for its use in higher-risk cases. The objective of this study was to determine the effectiveness of a single oral preoperative 2 g dose of cephalexin in preventing SSI following flap and graft dermatological closures on the nose and ear.
DESIGN:
Prospective double-blinded, randomised, placebo-controlled trial testing for difference in infection rates.
SETTING:
Primary care skin cancer clinics in North Queensland, Australia, were randomised to 2 g oral cephalexin or placebo 40-60 min prior to skin incision.
PARTICIPANTS:
154 consecutive eligible patients booked for flap or graft closure following skin cancer excision on the ear and nose.
INTERVENTION:
2 g dose of cephalexin administered 40-60 min prior to surgery.
RESULTS:
Overall 8/69 (11.6%) controls and 1/73 (1.4%) in the intervention group developed SSI (p=0.015; absolute SSI reduction 10.2%; number needed to treat (NNT) for benefit 9.8, 95% CI 5.5 to 45.5). In males, 7/44 controls and 0/33 in the intervention group developed SSI (p=0.018; absolute SSI reduction 15.9%; NNT for benefit 6.3, 95% CI 3.8 to 19.2). SSI was much lower in female controls (1/25) and antibiotic prophylaxis did not further reduce this (p=1.0). There was no difference between the study groups in adverse symptoms attributable to high-dose antibiotic administration (p=0.871).
CONCLUSION:
A single oral 2 g dose of cephalexin given before complex skin closure on the nose and ear reduced SSI.
TRIAL REGISTRATION NUMBER:
ANZCTR 365115; Post-results.
AuthorsHelena Rosengren, Clare F Heal, Petra G Buttner
JournalBMJ open (BMJ Open) Vol. 8 Issue 4 Pg. e020213 (04 19 2018) ISSN: 2044-6055 [Electronic] England
PMID29674370 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (administration & dosage)
  • Antibiotic Prophylaxis
  • Australia
  • Dermatologic Surgical Procedures (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nose (surgery)
  • Prospective Studies
  • Queensland
  • Staphylococcus aureus
  • Surgical Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: